MImAbs’in vivo immunopharmacology platform aims to test the therapeutic effect of an antibody in mouse models. The platformhas gathered a growing collection of murine models and, in partnership with the Centre for Immunophenomics (CIPHE), offers the possibility of developing new murine models when required.